Insider Transactions in Q3 2025 at Nektar Therapeutics (NKTR)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 09
2025
|
Howard W Robin President & CEO |
SELL
Open market or private sale
|
Direct |
6,666
-3.11%
|
$306,636
$46.81 P/Share
|
|
Sep 05
2025
|
Howard W Robin President & CEO |
SELL
Open market or private sale
|
Direct |
6,666
-3.67%
|
$253,308
$38.86 P/Share
|
|
Sep 04
2025
|
Howard W Robin President & CEO |
SELL
Open market or private sale
|
Direct |
5,166
-1.96%
|
$175,644
$34.03 P/Share
|
|
Sep 04
2025
|
Jonathan Zalevsky Chief R&D Officer |
SELL
Open market or private sale
|
Direct |
1,721
-2.32%
|
$58,514
$34.03 P/Share
|
|
Sep 02
2025
|
Howard W Robin President & CEO |
SELL
Open market or private sale
|
Direct |
1,500
-2.16%
|
$45,000
$30.16 P/Share
|
|
Sep 02
2025
|
Jonathan Zalevsky Chief R&D Officer |
SELL
Open market or private sale
|
Direct |
485
-2.47%
|
$14,550
$30.1 P/Share
|
|
Aug 19
2025
|
Jonathan Zalevsky Chief R&D Officer |
SELL
Open market or private sale
|
Direct |
725
-3.56%
|
$18,850
$26.59 P/Share
|
|
Aug 19
2025
|
Howard W Robin President & CEO |
SELL
Open market or private sale
|
Direct |
1,573
-2.22%
|
$40,898
$26.59 P/Share
|
|
Aug 19
2025
|
Mark Andrew Wilson Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
676
-3.22%
|
$17,576
$26.59 P/Share
|